U.S. Telecom Services and Carriers Stock News

If you are wondering whether Victoria's Secret stock still offers value after its recent run, this article will walk through what the current price might be telling you. The shares last closed at US$65.90, with returns of 23.5% over the past week, 20.9% over the last 30 days, 23.5% year to date, 75.4% over 1 year, and 71.7% over 3 years. Recent coverage has focused on Victoria's Secret as a standalone brand and retailer. Investors are paying close attention to how it is repositioning itself...

Earlier this month, DISCO Pharmaceuticals announced an exclusive license agreement granting Amgen global rights to develop and commercialize cancer therapies from DISCO’s cell-surface proteomics platform, with DISCO eligible for up to US$618 million in total deal value plus royalties. This partnership adds another specialized oncology program to Amgen’s pipeline at the same time that investors are closely watching its late-stage obesity and cardiovascular candidates. We’ll now examine how...

Brookfield Infrastructure stock snapshot Brookfield Infrastructure (BIPC) shares have retreated over the past month and past 3 months, with the stock closing at US$43.26. This may prompt investors to reassess the company’s current valuation and fundamentals. See our latest analysis for Brookfield Infrastructure. BIPC’s recent 1 month share price return of a 6.63% decline and 3 month share price return of a 5.07% decline contrast with a 1 year total shareholder return of 18.58%, suggesting...

Market reaction to sector headlines Qfin Holdings (QFIN) came under pressure after shares fell about 4.5%, as U.S. tariff uncertainty and concerns over China’s consumer credit environment weighed on China fintech ADRs and online lending sentiment. See our latest analysis for Qfin Holdings. That tariff driven drop comes on top of a 3.53% one day and 11.66% 30 day share price decline, together with a 35.19% 90 day share price fall and a 49.29% one year total shareholder return loss. This...

Adaptive Biotechnologies recently announced that its subsidiary Digital Biotechnologies, Inc. began a Series A Preferred Stock round targeting up to US$15,000,000 while retaining nearly half ownership, and entered two non-exclusive T-cell receptor discovery and immune data licensing agreements with Pfizer that could yield up to US$890,000,000 in milestone payments. An additional detail for investors is that these Pfizer agreements deepen Adaptive’s role in immune-driven drug development...

Aehr Test Systems (AEHR) is back in focus after securing more than US$5.5 million in new Sonoma burn in system orders tied to AI processors, reinstating second half fiscal 2026 revenue guidance, and introducing a fully automated Sonoma platform. See our latest analysis for Aehr Test Systems. The latest Sonoma orders and reinstated guidance arrive after a mixed few months, with a 1 day share price return of 15.95% and a 7 day share price return of 18.77% lifting sentiment after earlier...

Recently, Clear Secure director Adam Wiener executed his largest recorded open-market sale of 14,000 directly held shares under a pre-arranged Rule 10b5-1 trading plan, while the company also launched a free digital ID product active at more than 250 TSA checkpoints across the United States. This combination of insider activity and the rollout of a free, travel-focused digital identity service highlights Clear Secure’s evolving approach to broadening user access while managing insider share...

In recent days, Telephone and Data Systems drew fresh attention after Citi analyst Michael Rollins reaffirmed a positive view on the company’s prospects, citing ongoing progress in its review of assets such as UScellular and broadband operations. This renewed endorsement comes as investors continue to weigh how management’s exploration of options could influence the long-term shape of the business. We’ll now examine how Citi’s continued confidence in TDS’s strategic review affects the...

Setting the scene for BioLife Solutions (BLFS) BioLife Solutions (BLFS) has been drawing attention after recent share price moves, prompting investors to reassess how its current valuation lines up with its growth in bioproduction products and services for cell and gene therapy. See our latest analysis for BioLife Solutions. The recent move to a share price of $24.86 comes after a mixed period, with a 7 day share price return of 4.06% and a 90 day share price decline of 9.34%. The 1 year...

Cousins Properties recently drew attention after multiple analysts, including BMO Capital, upgraded their ratings, citing improving occupancy trends and a solid balance sheet across its Sun Belt office portfolio. These upgrades emphasized the relative resilience of Cousins’ Class A assets and leasing momentum in markets like Atlanta, Austin, and Charlotte, even as the broader office sector continues to face structural headwinds. We’ll now examine how this wave of analyst upgrades, centered...

In early January 2026, Hayward Holdings reported third-quarter 2025 results that exceeded market expectations on both earnings per share and revenue, while CEO Kevin Holleran exercised options to acquire 52,390 shares at US$1.40 and sold an equal number of shares for about US$837,899. The combination of better-than-expected quarterly performance and insider trading activity offers investors fresh information about Hayward’s operational momentum and leadership’s portfolio decisions. With...

In recent days, Barclays initiated coverage on Badger Meter with an Underweight/Sell rating, citing slowing demand growth for connected water meters as the market matures and pressures in utility spending. This cautious stance contrasts with a generally more positive analyst consensus and comes as Badger Meter maintains strong free cash flow, no debt, and continues investing in smart water technologies and new leadership. We’ll now examine how Barclays’ more cautious view on connected meter...

AutoNation, Inc. has recently expanded its footprint through acquisitions of Toyota in Baltimore, Audi and Mercedes-Benz in Chicago, and Groove Ford and Groove Mazda, while advancing its AutoNation Express digital platform to support online vehicle transactions. At the same time, the board’s approval of an additional US$1.00 billion in share repurchases signals a strong focus on capital returns and balance sheet-driven flexibility. We’ll now examine how this combination of fresh acquisitions...

ESAB recently signed its largest welding and handling equipment contract to date with Titan Wind Energy, supplying highly automated SAW lines, heavy-duty manipulators, and digitally controlled welding systems for Titan’s new monopile manufacturing facility in Cuxhaven. This agreement underscores ESAB’s role as a key technology supplier to offshore wind infrastructure, highlighting how its automation and real-time monitoring capabilities can support demanding 14‑metre‑class monopile...

Belden (BDC) is back in focus after the company appointed Brad Dineley as Executive Vice President, Chief Digital and Operations Officer, a global role reporting directly to the CEO effective January 5, 2026. See our latest analysis for Belden. The appointment of Dineley comes as Belden’s share price has eased in the short term, with a 30-day share price return showing a 6.87% decline and a 90-day share price return showing a 2.60% gain. The 5-year total shareholder return of 173.45% points...

With no single headline driving attention today, Texas Roadhouse (TXRH) has still been drawing interest after a stretch of positive returns, including roughly 7% over the past week and 9% over the past month. See our latest analysis for Texas Roadhouse. That recent 8.9% 1 month share price return sits alongside a 6.9% year to date share price gain, while the 3 year total shareholder return of 90.7% points to strong longer term momentum. If Texas Roadhouse has you looking more closely at...

Framing ExlService Holdings after recent performance ExlService Holdings (EXLS) has drawn attention after recent trading, with the stock closing at $42.68 and showing mixed return patterns over the past year. This has prompted a closer look at how the business is positioned today. See our latest analysis for ExlService Holdings. Recent trading has been relatively steady, with a 7 day share price return of 3.57% and a 90 day share price return of 4.58%. However, the 1 year total shareholder...

Banc of California recently reported strong third-quarter 2025 earnings that surpassed analyst expectations, continued its share repurchase program, and declared a quarterly cash dividend paid on January 2, 2026, highlighting its current focus on returning capital to shareholders. The bank’s evolution into a broader regional player following its Pacific Western merger, combined with active buybacks and dividends, is drawing attention to how its capital return policies fit with its...

In recent days, Donnelley Financial Solutions drew investor attention as capital shifted from high-growth technology names toward value-oriented financial services companies, amid optimism about tax cuts, easier financial conditions, and potential interest rate reductions in the United States. At the same time, the company introduced its Active Intelligence AI suite for the ActiveDisclosure platform, highlighting ongoing product innovation that complements this macro-driven reappraisal of...

Yum! Brands has recently begun a formal review of options for its underperforming Pizza Hut business under new leadership, signaling that parts of the brand’s turnaround may ultimately be pursued outside the group. This process, supported by major financial advisors and unfolding alongside mixed analyst ratings, underscores how Pizza Hut’s future structure could materially influence Yum!’s overall business profile. We’ll now examine how the formal Pizza Hut strategic review could reshape...

Ascendis Pharma recently reported past Week 52 topline results from its Phase 2 COACH trial, showing that once-weekly TransCon CNP plus TransCon hGH in children with achondroplasia delivered durable growth, improved body proportionality and arm span, and a safety profile consistent with the monotherapies. The data, alongside TransCon CNP’s ongoing FDA Priority Review for achondroplasia, highlights the company’s ambition to position TransCon CNP as a backbone therapy targeting the condition’s...

In recent days, Jim Cramer repeatedly described SI-BONE as a “great, great speculation” on air, drawing attention to its minimally invasive sacropelvic implants and broader musculoskeletal device portfolio. His comments, combined with fresh analyst coverage and insider sales tied to tax withholding and Rule 10b5-1 plans, have sharpened focus on how media visibility, governance practices, and medical device innovation intersect for this company. Next, we’ll examine how Cramer’s “great, great...

Pitney Bowes recently advanced its restructuring efforts, focusing on simplifying its portfolio, exiting underperforming operations, and tightening cost controls in international parcel activities, which has heightened attention on execution risks. This shift has turned Pitney Bowes into a high-volatility turnaround story, with analysts emphasizing the need for clear progress on debt reduction and margin improvement before it can be viewed as a core holding. Next, we’ll examine how this...

Recent industry reports point to rising global demand for agricultural lime, as farmers focus more on sustainable practices and soil health. United States Lime & Minerals (USLM) features prominently as a key producer in this expanding niche. See our latest analysis for United States Lime & Minerals. Against this backdrop, United States Lime & Minerals’ share price is at $130.44, with a 7.84% year to date share price return and a 9.74% 1 year total shareholder return. The 3 year total...